Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

211
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
211
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

913
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
913

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midline signaling regulates kidney positioning but not nephrogenesis through Shh.

Developmental biology·2010
Same author

Y chromosomal STR polymorphism in northern Chinese populations.

Biological research·2010
Same author

Construction of NF-κB-targeting RNAi adenovirus vector and the effect of NF-κB pathway on proliferation and apoptosis of vascular endothelial cells.

Molecular biology reports·2010
Same author

Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2010
Same author

Hydrothermal synthesis of nanostructures Bi12TiO20 and their photocatalytic activity on acid orange 7 under visible light.

Chemosphere·2010
Same author

An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.

Biomaterials·2010

Related Experiment Video

Updated: May 24, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Prediction of drug target interaction based on under sampling strategy and random forest algorithm.

Feng Chen1, Zhigang Zhao2, Zheng Ren2

  • 1School of Advanced Manufacturing Engineering, Hefei University, Hefei, China.

Plos One
|March 6, 2025
PubMed
Summary

This study introduces an improved computational method for predicting drug target interactions (DTIs). The enhanced random forest model accurately identifies DTIs, overcoming limitations of existing approaches for drug discovery.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.6K

Related Experiment Videos

Last Updated: May 24, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.6K

Area of Science:

  • Computational chemistry and bioinformatics
  • Drug discovery and development
  • Pharmacology

Background:

  • Drug target interactions (DTIs) are vital for drug discovery but experimental identification is costly and time-consuming.
  • Current computational DTI prediction models face challenges with accuracy and high false positive rates, particularly with imbalanced datasets.
  • Developing efficient computational methods is crucial to accelerate the identification of novel drug-target relationships.

Purpose of the Study:

  • To develop a highly accurate computational method for predicting drug target interactions (DTIs).
  • To address the limitations of existing models, specifically their performance on unbalanced datasets.
  • To enhance the efficiency and reliability of DTI prediction in drug discovery pipelines.

Main Methods:

  • Extraction of comprehensive descriptors for drugs and target proteins.
  • Application of an integrated random forest (RF) model for DTI prediction.
  • Utilizing random projection for feature dimension reduction to simplify model calculations.
  • Employing the NearMiss (NM) down-sampling technique to balance sample categories in datasets.

Main Results:

  • The proposed method achieved high area under the receiver operating characteristic curve (auROC) scores across gold standard datasets: 92.26% (nuclear receptors), 98.21% (ion channel), 97.65% (GPCRs), and 99.33% (enzymes).
  • Demonstrated significantly superior performance compared to state-of-the-art methods in predicting drug target interactions.
  • The combination of feature reduction and sample balancing effectively improved prediction accuracy.

Conclusions:

  • The developed computational approach significantly enhances the accuracy of drug target interaction prediction.
  • The method effectively handles imbalanced datasets, a common challenge in DTI prediction.
  • This work offers a promising tool to aid in the efficient and cost-effective discovery of new drugs.